All Type of News
Sanofi-Aventis Korea to embark on clinical training
A group of 37 pharmacists and nurses who will graduate from 11 local universities will receive a two-day clinical training academy to be hosted by Sanofi-Aventis Korea between November 23-24.
Sanofi-Aventis Korea s...
Daewoong launches flurbiprofen patchDaewoong Pharm has released flubiprofen patch (trade name: Penostop menthol plaster) with a potent analgesic and anti-inflammatory action.
Unlike ketoprofen or piroxicam patc...
|
Prices of 1,451 medicines to be reduced from next January
The government plans to lower the insurance prices of frequently prescribed 1,451 drugs (chiefly antibiotics, anti-malignant tumor drugs, anti-diabetics) by 13.3% on average from January 1, 2008 as a result of i...
Fosamax Plus patent doesn't belong to patent scope of Maxmarvil, Intellectual Property Tribunal says
The Korea Intellectual Property Tribunal rejected Yuyu Pharm's request to confirm whether MSD Korea's Fosamax Plus (70 mg alendronate/5,600 IU vitamin D3) is not in the patent scope of Yuyu's Maxmarvil (Korean Patent ...
Drug makers face tough times
Local pharmaceutical firms are facing tough times ahead as the Korean won's rise against the U.S. dollar, stemming from growing worries over economic woes of the world's largest economy, has prompted the government to...
Emin Turan named new president of Sanofi PasteurSanofi Pasteur Korea has appointed Emin Turan, the vaccines business of Sanofi Aventis Group, as president effective October 25.
The company is providing superior, innovative...
|
Daewoong unveils stomatitis medicationDaewoong has unveiled its supplemental agent (trade name: Impactamine, 12 tablets per pack) for relieving stomatitis, inflammation of the oral mucosa, from this month.
Accord...
|
Government to cover cost-effective medicines
The government reaffirmed its plan to ask the national health insurance to cover only cost-effective drugs to reduce snowballing medication costs as an increasing number
of patients are taking more expensive and dive...
Government to toughen bioequivalence rules
The government unveiled its plan to revise the current criteria of bioequivalence testing from July next year.
In a seminar on November 15, Myung Kyung-min, an official of the Korea Food and Drug Administration, sa...
Chung pledges to promote medical industryPresidential candidate Chung Dong-young of the United New Democratic Party (UNDP) pledged to transfer local medical industry into one of the nation's sophisticated sectors.
P...
|
